Open AccessInfluenza A/H1N1 Vaccine in Patients Treated by Kidney Transplant or Dialysis
Author(s) -
Nilufer E. Broeders,
Anneleen Hombrouck,
Anne Lemy,
Karl Martin Wissing,
Judith Racapé,
Karine Gastaldello,
Annick Massart,
Steven Van Gucht,
Laura Weichselbaum,
Aurélie De Mul,
B. Brochier,
Isabelle Thomas,
Daniel Abramowicz
Publication year - 2011
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.04670511
Subject(s) - medicine , vaccination , seroconversion , immunology , immunogenicity , influenza vaccine , immunization , titer , antigen , antibody
In 2009, the pandemic influenza A/H1N1 accounted for worldwide recommendations about vaccination. There are few data concerning the immunogenicity or the security of the adjuvanted-A/H1N1 vaccine in transplanted and hemodialyzed patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom